CTNM

Contineum Therapeutics, Inc.

Insider trading activity for Contineum Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$1.1M

net selling

Bought(0 · 0 insiders): $0
Sold(10 · 3 insiders): $1.1M

Past 6 months

-$1.2M

net selling

Bought(0 · 0 insiders): $0
Sold(14 · 3 insiders): $1.2M

Past 12 months

-$1.9M

net selling

Bought(0 · 0 insiders): $0
Sold(31 · 3 insiders): $1.9M

Transaction history

The 93 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 8	Stengone Carmine N.	CEO and President	MEXER◷◆	2,500	—	—	—	Open the original filing on SEC.gov
Sep 8	Stengone Carmine N.	CEO and President	SSELL◷	2,500	$16.46	$41.1K	-12.7%	Open the original filing on SEC.gov
Sep 8	Stengone Carmine N.	CEO and President	MEXER◷	2,500	$1.01	$2.5K	+14.5%	Open the original filing on SEC.gov
Aug 3	Stengone Carmine N.	CEO and President	MEXER◷◆	2,500	—	—	—	Open the original filing on SEC.gov
Aug 3	Stengone Carmine N.	CEO and President	SSELL◷	2,500	$16.01	$40K	-12.7%	Open the original filing on SEC.gov
Aug 3	Stengone Carmine N.	CEO and President	MEXER◷	2,500	$1.01	$2.5K	+14.5%	Open the original filing on SEC.gov
Jul 9	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	25	—	—	—	Open the original filing on SEC.gov
Jul 9	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	25	$16.00	$400	<0.1%	Open the original filing on SEC.gov
Jul 9	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	25	$1.01	$25	+<0.1%	Open the original filing on SEC.gov
Jul 8	Stengone Carmine N.	CEO and President	MEXER◷◆	2,500	—	—	—	Open the original filing on SEC.gov
Jul 8	Stengone Carmine N.	CEO and President	SSELL◷	2,500	$16.00	$40K	-12.7%	Open the original filing on SEC.gov
Jul 8	Stengone Carmine N.	CEO and President	MEXER◷	2,500	$1.01	$2.5K	+14.5%	Open the original filing on SEC.gov
Jul 8	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	1,015	—	—	—	Open the original filing on SEC.gov
Jul 8	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	1,015	$16.00	$16.2K	-0.8%	Open the original filing on SEC.gov
Jul 8	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	1,015	$1.01	$1K	+0.8%	Open the original filing on SEC.gov
Jul 1	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	4,183	—	—	—	Open the original filing on SEC.gov
Jul 1	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	2,501	$16.24	$40.6K	-1.8%	Open the original filing on SEC.gov
Jul 1	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	5,852	$15.67	$91.7K	-4.1%	Open the original filing on SEC.gov
Jul 1	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	4,183	$1.01	$4.2K	+3.0%	Open the original filing on SEC.gov
Jun 30	Watkins Tim	CMO & Head of Developmen…	MEXER◷◆	10,833	—	—	—	Open the original filing on SEC.gov
Jun 30	Watkins Tim	CMO & Head of Developmen…	SSELL◷	10,833	$16.02	$173.6K	-54.7%	Open the original filing on SEC.gov
Jun 30	Watkins Tim	CMO & Head of Developmen…	MEXER◷	10,833	$4.50	$48.7K	+120.9%	Open the original filing on SEC.gov
Jun 30	Stengone Carmine N.	CEO and President	MEXER◷◆	2,500	—	—	—	Open the original filing on SEC.gov
Jun 30	Stengone Carmine N.	CEO and President	MEXER◷◆	7,500	—	—	—	Open the original filing on SEC.gov
Jun 30	Stengone Carmine N.	CEO and President	SSELL◷	10,000	$16.01	$160.1K	-36.7%	Open the original filing on SEC.gov
Jun 30	Stengone Carmine N.	CEO and President	MEXER◷	2,500	$1.26	$3.2K	+10.1%	Open the original filing on SEC.gov
Jun 30	Stengone Carmine N.	CEO and President	MEXER◷	7,500	$1.01	$7.6K	+43.6%	Open the original filing on SEC.gov
Jun 30	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	28,826	—	—	—	Open the original filing on SEC.gov
Jun 30	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	28,826	$16.04	$462.3K	-17.1%	Open the original filing on SEC.gov
Jun 30	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	28,826	$1.01	$29.1K	+20.7%	Open the original filing on SEC.gov
Jun 26	Miralles Gines Diego	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Lyons-Williams Lori	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Ware Olivia C	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Schimmelpennink Evert B.	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Ignelzi Troy A.	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Brady Todd R.	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 26	Boyce Sarah	Director	AGRANT◆	19,000	—	—	—	Open the original filing on SEC.gov
Jun 1	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	4,170	$13.16	$54.9K	-2.9%	Open the original filing on SEC.gov
May 1	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	300	$13.84	$4.2K	-0.2%	Open the original filing on SEC.gov
May 1	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	3,870	$13.06	$50.5K	-2.6%	Open the original filing on SEC.gov
Apr 6	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	4,170	$13.43	$56K	-2.8%	Open the original filing on SEC.gov
Mar 2	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	4,170	$15.01	$62.6K	-2.7%	Open the original filing on SEC.gov
Mar 2	Watkins Tim	CMO & Head of Developmen…	MEXER◷◆	3,611	—	—	—	Open the original filing on SEC.gov
Mar 2	Watkins Tim	CMO & Head of Developmen…	SSELL◷	3,611	$15.02	$54.2K	-100.0%	Open the original filing on SEC.gov
Mar 2	Watkins Tim	CMO & Head of Developmen…	MEXER◷	3,611	$4.50	$16.2K	—	Open the original filing on SEC.gov
Feb 25	Stengone Carmine N.	CEO and President	MEXER◷◆	2,700	—	—	—	Open the original filing on SEC.gov
Feb 25	Stengone Carmine N.	CEO and President	SSELL◷	2,700	$16.02	$43.2K	-15.3%	Open the original filing on SEC.gov
Feb 25	Stengone Carmine N.	CEO and President	MEXER◷	2,700	$1.26	$3.4K	+18.1%	Open the original filing on SEC.gov
Feb 25	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	3,824	—	—	—	Open the original filing on SEC.gov
Feb 25	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	3,824	$16.01	$61.2K	-2.4%	Open the original filing on SEC.gov
Feb 25	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	3,824	$1.01	$3.9K	+2.5%	Open the original filing on SEC.gov
Feb 24	Stengone Carmine N.	CEO and President	MEXER◷◆	4,400	—	—	—	Open the original filing on SEC.gov
Feb 24	Stengone Carmine N.	CEO and President	SSELL◷	4,400	$16.02	$70.5K	-22.7%	Open the original filing on SEC.gov
Feb 24	Stengone Carmine N.	CEO and President	MEXER◷	4,400	$1.26	$5.5K	+29.4%	Open the original filing on SEC.gov
Feb 24	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	4,300	—	—	—	Open the original filing on SEC.gov
Feb 24	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	4,300	$16.03	$68.9K	-2.7%	Open the original filing on SEC.gov
Feb 24	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	4,300	$1.01	$4.3K	+2.8%	Open the original filing on SEC.gov
Feb 19	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	100	—	—	—	Open the original filing on SEC.gov
Feb 19	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	100	$16.00	$1.6K	<0.1%	Open the original filing on SEC.gov
Feb 19	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	100	$1.01	$101	+<0.1%	Open the original filing on SEC.gov
Feb 11	Stengone Carmine N.	CEO and President	MEXER◷◆	400	—	—	—	Open the original filing on SEC.gov
Feb 11	Stengone Carmine N.	CEO and President	SSELL◷	400	$16.00	$6.4K	-2.6%	Open the original filing on SEC.gov
Feb 11	Stengone Carmine N.	CEO and President	MEXER◷	400	$1.26	$504	+2.7%	Open the original filing on SEC.gov
Feb 11	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷◆	400	—	—	—	Open the original filing on SEC.gov
Feb 11	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	400	$16.00	$6.4K	-0.3%	Open the original filing on SEC.gov
Feb 11	Lorrain Daniel S.	Chief Scientific Officer	MEXER◷	400	$1.01	$404	+0.3%	Open the original filing on SEC.gov
Feb 3	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	1,170	$15.25	$17.8K	-0.7%	Open the original filing on SEC.gov
Feb 3	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	3,000	$14.82	$44.5K	-1.9%	Open the original filing on SEC.gov
Jan 30	Healy John Stephen	General Counsel and…	AGRANT◆	206,411	—	—	—	Open the original filing on SEC.gov
Jan 30	Slover Peter T	Chief Financial Officer	AGRANT◆	192,000	—	—	—	Open the original filing on SEC.gov
Jan 30	Stengone Carmine N.	CEO and President	AGRANT◆	445,000	—	—	—	Open the original filing on SEC.gov
Jan 30	Lorrain Daniel S.	Chief Scientific Officer	AGRANT◆	6,500	—	—	—	Open the original filing on SEC.gov
Jan 30	Lorrain Daniel S.	Chief Scientific Officer	AGRANT◆	160,000	—	—	—	Open the original filing on SEC.gov
Jan 30	Watkins Tim	CMO & Head of Developmen…	AGRANT◷◆	160,000	—	—	—	Open the original filing on SEC.gov
Jan 28	Watkins Tim	CMO & Head of Developmen…	MEXER◷◆	3,611	—	—	—	Open the original filing on SEC.gov
Jan 28	Watkins Tim	CMO & Head of Developmen…	SSELL◷	811	$14.48	$11.7K	-100.0%	Open the original filing on SEC.gov
Jan 28	Watkins Tim	CMO & Head of Developmen…	SSELL◷	2,800	$14.09	$39.4K	-77.5%	Open the original filing on SEC.gov
Jan 28	Watkins Tim	CMO & Head of Developmen…	MEXER◷	3,611	$4.50	$16.2K	—	Open the original filing on SEC.gov
Jan 5	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	500	$11.13	$5.6K	-0.3%	Open the original filing on SEC.gov
Jan 5	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	3,670	$10.35	$38K	-2.2%	Open the original filing on SEC.gov
Dec 29, 2025	Watkins Tim	CMO & Head of Developmen…	MEXER◷◆	3,611	—	—	—	Open the original filing on SEC.gov
Dec 29, 2025	Watkins Tim	CMO & Head of Developmen…	SSELL◷	3,611	$12.06	$43.6K	-100.0%	Open the original filing on SEC.gov
Dec 29, 2025	Watkins Tim	CMO & Head of Developmen…	MEXER◷	3,611	$4.50	$16.2K	—	Open the original filing on SEC.gov
Dec 23, 2025	Lorrain Daniel S.	Chief Scientific Officer	SSELL◷	4,170	$12.23	$51K	-2.5%	Open the original filing on SEC.gov
Jun 26, 2025	Schimmelpennink Evert B.	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Ignelzi Troy A.	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Lyons-Williams Lori	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Ware Olivia C	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Miralles Gines Diego	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Brady Todd R.	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Jun 26, 2025	Boyce Sarah	Director	AGRANT◆	14,750	—	—	—	Open the original filing on SEC.gov
Apr 28, 2025	Watkins Tim	CMO & Head of Developmen…	AGRANT◆	26,000	—	—	—	Open the original filing on SEC.gov
Apr 28, 2025	Watkins Tim	CMO & Head of Developmen…	AGRANT◆	260,000	—	—	—	Open the original filing on SEC.gov

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentSep 8

2,500 sh

SSELL◷$41.1K

Stengone Carmine N. · CEO and PresidentSep 8

2,500 sh @ $16.46 · -12.7% own

MEXER◷$2.5K

Stengone Carmine N. · CEO and PresidentSep 8

2,500 sh @ $1.01 · +14.5% own

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentAug 3

2,500 sh

SSELL◷$40K

Stengone Carmine N. · CEO and PresidentAug 3

2,500 sh @ $16.01 · -12.7% own

MEXER◷$2.5K

Stengone Carmine N. · CEO and PresidentAug 3

2,500 sh @ $1.01 · +14.5% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Jul 9

25 sh

SSELL◷$400

Lorrain Daniel S. · Chief Scientific…Jul 9

25 sh @ $16.00 · <0.1% own

MEXER◷$25

Lorrain Daniel S. · Chief Scientific…Jul 9

25 sh @ $1.01 · +<0.1% own

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentJul 8

2,500 sh

SSELL◷$40K

Stengone Carmine N. · CEO and PresidentJul 8

2,500 sh @ $16.00 · -12.7% own

MEXER◷$2.5K

Stengone Carmine N. · CEO and PresidentJul 8

2,500 sh @ $1.01 · +14.5% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Jul 8

1,015 sh

SSELL◷$16.2K

Lorrain Daniel S. · Chief Scientific…Jul 8

1,015 sh @ $16.00 · -0.8% own

MEXER◷$1K

Lorrain Daniel S. · Chief Scientific…Jul 8

1,015 sh @ $1.01 · +0.8% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Jul 1

4,183 sh

SSELL◷$40.6K

Lorrain Daniel S. · Chief Scientific…Jul 1

2,501 sh @ $16.24 · -1.8% own

SSELL◷$91.7K

Lorrain Daniel S. · Chief Scientific…Jul 1

5,852 sh @ $15.67 · -4.1% own

MEXER◷$4.2K

Lorrain Daniel S. · Chief Scientific…Jul 1

4,183 sh @ $1.01 · +3.0% own

MEXER◷◆—

Watkins Tim · CMO & Head of…Jun 30

10,833 sh

SSELL◷$173.6K

Watkins Tim · CMO & Head of…Jun 30

10,833 sh @ $16.02 · -54.7% own

MEXER◷$48.7K

Watkins Tim · CMO & Head of…Jun 30

10,833 sh @ $4.50 · +120.9% own

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentJun 30

2,500 sh

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentJun 30

7,500 sh

SSELL◷$160.1K

Stengone Carmine N. · CEO and PresidentJun 30

10,000 sh @ $16.01 · -36.7% own

MEXER◷$3.2K

Stengone Carmine N. · CEO and PresidentJun 30

2,500 sh @ $1.26 · +10.1% own

MEXER◷$7.6K

Stengone Carmine N. · CEO and PresidentJun 30

7,500 sh @ $1.01 · +43.6% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Jun 30

28,826 sh

SSELL◷$462.3K

Lorrain Daniel S. · Chief Scientific…Jun 30

28,826 sh @ $16.04 · -17.1% own

MEXER◷$29.1K

Lorrain Daniel S. · Chief Scientific…Jun 30

28,826 sh @ $1.01 · +20.7% own

AGRANT◆—

Miralles Gines Diego · DirectorJun 26

19,000 sh

AGRANT◆—

Lyons-Williams Lori · DirectorJun 26

19,000 sh

AGRANT◆—

Ware Olivia C · DirectorJun 26

19,000 sh

AGRANT◆—

Schimmelpennink Evert B. · DirectorJun 26

19,000 sh

AGRANT◆—

Ignelzi Troy A. · DirectorJun 26

19,000 sh

AGRANT◆—

Brady Todd R. · DirectorJun 26

19,000 sh

AGRANT◆—

Boyce Sarah · DirectorJun 26

19,000 sh

SSELL◷$54.9K

Lorrain Daniel S. · Chief Scientific…Jun 1

4,170 sh @ $13.16 · -2.9% own

SSELL◷$4.2K

Lorrain Daniel S. · Chief Scientific…May 1

300 sh @ $13.84 · -0.2% own

SSELL◷$50.5K

Lorrain Daniel S. · Chief Scientific…May 1

3,870 sh @ $13.06 · -2.6% own

SSELL◷$56K

Lorrain Daniel S. · Chief Scientific…Apr 6

4,170 sh @ $13.43 · -2.8% own

SSELL◷$62.6K

Lorrain Daniel S. · Chief Scientific…Mar 2

4,170 sh @ $15.01 · -2.7% own

MEXER◷◆—

Watkins Tim · CMO & Head of…Mar 2

3,611 sh

SSELL◷$54.2K

Watkins Tim · CMO & Head of…Mar 2

3,611 sh @ $15.02 · -100.0% own

MEXER◷$16.2K

Watkins Tim · CMO & Head of…Mar 2

3,611 sh @ $4.50

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentFeb 25

2,700 sh

SSELL◷$43.2K

Stengone Carmine N. · CEO and PresidentFeb 25

2,700 sh @ $16.02 · -15.3% own

MEXER◷$3.4K

Stengone Carmine N. · CEO and PresidentFeb 25

2,700 sh @ $1.26 · +18.1% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Feb 25

3,824 sh

SSELL◷$61.2K

Lorrain Daniel S. · Chief Scientific…Feb 25

3,824 sh @ $16.01 · -2.4% own

MEXER◷$3.9K

Lorrain Daniel S. · Chief Scientific…Feb 25

3,824 sh @ $1.01 · +2.5% own

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentFeb 24

4,400 sh

SSELL◷$70.5K

Stengone Carmine N. · CEO and PresidentFeb 24

4,400 sh @ $16.02 · -22.7% own

MEXER◷$5.5K

Stengone Carmine N. · CEO and PresidentFeb 24

4,400 sh @ $1.26 · +29.4% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Feb 24

4,300 sh

SSELL◷$68.9K

Lorrain Daniel S. · Chief Scientific…Feb 24

4,300 sh @ $16.03 · -2.7% own

MEXER◷$4.3K

Lorrain Daniel S. · Chief Scientific…Feb 24

4,300 sh @ $1.01 · +2.8% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Feb 19

100 sh

SSELL◷$1.6K

Lorrain Daniel S. · Chief Scientific…Feb 19

100 sh @ $16.00 · <0.1% own

MEXER◷$101

Lorrain Daniel S. · Chief Scientific…Feb 19

100 sh @ $1.01 · +<0.1% own

MEXER◷◆—

Stengone Carmine N. · CEO and PresidentFeb 11

400 sh

SSELL◷$6.4K

Stengone Carmine N. · CEO and PresidentFeb 11

400 sh @ $16.00 · -2.6% own

MEXER◷$504

Stengone Carmine N. · CEO and PresidentFeb 11

400 sh @ $1.26 · +2.7% own

MEXER◷◆—

Lorrain Daniel S. · Chief Scientific…Feb 11

400 sh

SSELL◷$6.4K

Lorrain Daniel S. · Chief Scientific…Feb 11

400 sh @ $16.00 · -0.3% own

MEXER◷$404

Lorrain Daniel S. · Chief Scientific…Feb 11

400 sh @ $1.01 · +0.3% own

SSELL◷$17.8K

Lorrain Daniel S. · Chief Scientific…Feb 3

1,170 sh @ $15.25 · -0.7% own

SSELL◷$44.5K

Lorrain Daniel S. · Chief Scientific…Feb 3

3,000 sh @ $14.82 · -1.9% own

AGRANT◆—

Healy John Stephen · General Counsel…Jan 30

206,411 sh

AGRANT◆—

Slover Peter T · Chief Financial…Jan 30

192,000 sh

AGRANT◆—

Stengone Carmine N. · CEO and PresidentJan 30

445,000 sh

AGRANT◆—

Lorrain Daniel S. · Chief Scientific…Jan 30

6,500 sh

AGRANT◆—

Lorrain Daniel S. · Chief Scientific…Jan 30

160,000 sh

AGRANT◷◆—

Watkins Tim · CMO & Head of…Jan 30

160,000 sh

MEXER◷◆—

Watkins Tim · CMO & Head of…Jan 28

3,611 sh

SSELL◷$11.7K

Watkins Tim · CMO & Head of…Jan 28

811 sh @ $14.48 · -100.0% own

SSELL◷$39.4K

Watkins Tim · CMO & Head of…Jan 28

2,800 sh @ $14.09 · -77.5% own

MEXER◷$16.2K

Watkins Tim · CMO & Head of…Jan 28

3,611 sh @ $4.50

SSELL◷$5.6K

Lorrain Daniel S. · Chief Scientific…Jan 5

500 sh @ $11.13 · -0.3% own

SSELL◷$38K

Lorrain Daniel S. · Chief Scientific…Jan 5

3,670 sh @ $10.35 · -2.2% own

MEXER◷◆—

Watkins Tim · CMO & Head of…Dec 29, 2025

3,611 sh

SSELL◷$43.6K

Watkins Tim · CMO & Head of…Dec 29, 2025

3,611 sh @ $12.06 · -100.0% own

MEXER◷$16.2K

Watkins Tim · CMO & Head of…Dec 29, 2025

3,611 sh @ $4.50

SSELL◷$51K

Lorrain Daniel S. · Chief Scientific…Dec 23, 2025

4,170 sh @ $12.23 · -2.5% own

AGRANT◆—

Schimmelpennink Evert B. · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Ignelzi Troy A. · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Lyons-Williams Lori · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Ware Olivia C · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Miralles Gines Diego · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Brady Todd R. · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Boyce Sarah · DirectorJun 26, 2025

14,750 sh

AGRANT◆—

Watkins Tim · CMO & Head of…Apr 28, 2025

26,000 sh

AGRANT◆—

Watkins Tim · CMO & Head of…Apr 28, 2025

260,000 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

1 of 15 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 1 business day late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Dec 23, 2025	Dec 29, 2025	Lorrain Daniel S.Chief Scientific Officer	1day	$51K	Filing ↗

Lorrain Daniel S.Chief Scientific Officer

1day

Traded Dec 23, 2025 · filed Dec 29, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →